TABLE 2.
Human cancer viruses: mechanisms of immune evasion
Virus | Abbreviation(s) | MHC regulation | Interferon pathway change(s) | Molecular mimicry | Escape mutants | Reference(s) |
---|---|---|---|---|---|---|
Human papillomaviruses 16 and 18 | HPV16, HPV18 | LMP2 and LMP7 ↓, TAP1 and TAP2 ↓, MHC-I ↓ | TLR9 ↓ | 161, 168 | ||
Epstein-Barr virus | EBV, HHV-4 | TAP ↓ by BNLF2a, MHC-I ↓ by BNLF5, TAP1 ↓ by vIL-10, MHC-I ↓ by BILF1, MHC-II ↓ by gp42/gH/gL, BGLF5, and vIL-10 | Tyk2↓ by LMP-1, TLR9 ↓ by LMP-1 | 157–159, 164, 169 | ||
Kaposi's sarcoma-associated herpesvirus | KSHV, HHV-8 | MHC-I ↓ by MIR1 and MIR2 | IFN signaling ↓ by RIF | v-CCL-1, v-CCL-2, v-CCL-3, v-FLICE | 174, 175, 178 | |
Hepatitis B virus | HBV | MHC-I ↓ | IFN-α and IFN-β ↓ | Env mimics IgA | Yes | 160, 167, 179, 182 |
Hepatitis C virus | HCV | RIG-1 ↓ by NS3/4A, TRIF ↓ by NS3/4A, IL-8 ↑ by NS5A | Yes | 172, 173 | ||
Human adult T-cell leukemia virus | HTLV-1 | TLR4 signaling ↓ by p30 | 149 | |||
Merkel cell polyomavirus | MCV, MCPyV | TLR9 ↓ by T-Ag | 170 |